Money
Filter News
Found 55,584 articles
-
CAR-T therapy is the big thing right now, with this week's approval of Gilead Yescarta and the recent approval of Novartis' Kymriah.
-
Analysts with SunTrust Robinson Humphrey recently published a research report that looked at a number of large-cap pharma companies.
-
The company was among dozens of firms worldwide hit in the June 27 attack.
-
Immune Pharma Announces Pricing of $18M Public Offering of Convertible Preferred Stock and Warrants
10/20/2017
The offering will be comprised of units, priced at a public offering price of $1,000 per unit.
-
Concordia Takes Next Step to Realign Its Capital Structure By Commencing Proceedings Under the Canada Business Corporations Act
10/20/2017
Concordia today announced that it has taken a further step in its previously announced efforts to realign its capital structure by commencing a court proceeding under the CBCA.
-
Ignyta Announces Pricing of Public Offering of Common Stock of 10 Million Share
10/20/2017
Ignyta, Inc., a biotechnology company focused on precision medicine in oncology, today announced the pricing of an underwritten public offering of 10.0 million shares of its common stock at a price to the public of $16.00 per share.
-
Helix BioPharma Corp. Closes Private Placement
10/20/2017
Helix BioPharma, an immuno-oncology company developing innovative drug candidates for the prevention and treatment of cancer, today announced it has closed a private placement financing for gross proceeds of approximately CAD3,909,600.
-
Bay Area's Eargo Scores $45M Series C
10/20/2017
The new investment was led by Nan Fung Life Sciences and also included investments from New Enterprise Associates NEA, Charles and Helen Schwab, and Maveron. -
RenovaCare Closes Registered Direct Offering and Concurrent Private Placement of 915,000 Shares
10/20/2017
RenovaCare announced that it has entered into definitive agreements with investors to purchase an aggregate of approximately 915,000 shares of common stock in a registered direct offering and common stock purchase warrants in a concurrent private placement.
-
EchoPixel Raises $8.5M Series A Financing Led by Intel Capital
10/20/2017
EchoPixel announced today that it has closed an $8.5M Series A financing.
-
Mergenet Solutions Issues Dividend
10/20/2017
Mergenet Solutions of Coconut Creek, FL has declared a cash dividend.
-
WalletHub recently examined the quarterly filings of hedge funds to determine which stocks they’re buying the most.
-
EnteroMedics recently filed with the SEC that it had raised $61M in a new equity financing round. There were 13 anonymous investors.
-
Allergan issued the FAQ document following the U.S. District Court's decision on the RESTASIS patents announced earlier this week.
-
Anatara Lifesciences Investor Presentation This Week
10/19/2017
Anatara Lifesciences is pleased to release its latest institutional roadshow presentation and market update that will be delivered to investors this week by CEO - chairman, Dr Mel Bridges and Co-Founder and Chief Scientific Officer, Dr Tracey Mynott.
-
FluGen Awarded $14.4 million by the Department of Defense to Test Universal Flu Vaccine Against Mismatched Strains
10/19/2017
FluGen Inc., announced today that it has been awarded a grant of $14.4 million through the DOD's Congressionally Directed Medical Research Programs Peer Reviewed Medical Research Program's (PRMRP) mechanism to conduct clinical challenge-studies against mismatched influenza strains with its lead universal flu vaccine, RedeeFlu.
-
Ampio Announces Closing of Registered Direct Offering
10/19/2017
Ampio today announced that it has closed it's previously announced registered direct offering of 7,709,400 shares of common stock at a purchase price of $0.875 per share for gross proceeds of approximately $6.75M.
-
Catalent Completes Repricing And Extension Of Credit Agreement
10/19/2017
Catalent today announced that its wholly owned subsidiary, Catalent Pharma Solutions, Inc. (the "Catalent Operating Subsidiary"), has completed an amendment to its senior secured credit facilities to lower the interest rate on its U.S. dollar-denominated and euro-denominated term loans and its revolving loans.
-
Marapharm Ventures Announces that it has Purchased an Additional 1.5 Million Units of Veritas Pharma Inc.
10/19/2017
Marapharm Ventures announces that it has today filed an early warning report advising that it has purchased a total of 1,500,000 units of Veritas Pharma at a purchase price of $0.28 per unit.
-
Abeona Announces Closing of $92M Underwritten Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares
10/19/2017
This includes the full exercise of the underwriters’ option to purchase 750,000 additional shares, at the public offering price of $16.00 per share.